Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

Register using your

DRUG MARKETING back to topic

What Ills Can the Pfizer-Wyeth Merger Cure?

Wharton professors weigh in on the pros and cons of the deal.

knowledge.wharton.upenn.edu. Added by Arlene Weintraub on February 5, 2009

report

save

This article has:

Cathy Arnst shared a reaction in Pfizer 1204 days ago

“two Wharton professors discuss merger”

report

Date

Type Channel Author

Search Cancel